📰 13 sources covering this story

Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug

First covered 2 days ago · latest take 1 hrs ago. Compare how each outlet is covering it — and rate the sources you trust.

Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug
Quartz
Quartz3 hrs ago
Eli Lilly is suing six companies over illegal sales of its unapproved weight loss drug
The drug remains in Phase 3 clinical trials and has not been approved by any regulator for human use
MarketWatch
MarketWatch1 hrs ago
Eli Lilly is suing pharmacies and peptide vendors over sale of its next big weight-loss drug: retatrutide
Some Americans have turned to medical spas and pharmacies that sell peptides for health and wellness benefits for access to compounded versions of retatrutide.
Eli Lilly Sues Sellers of Black Market Weight-Loss Drugs - WSJ
Eli Lilly Sues Sellers of Black Market Weight-Loss Drugs  WSJ
Reuters
Reuters4 hrs ago
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide
Lilly sues six companies over alleged illegal sales of experimental obesity drug retatrutide  Reuters
CBS News
CBS News4 hrs ago
Eli Lilly takes aim at illicit market for its experimental weight-loss drug
The pharmaceutical company is filing lawsuits against six outlets selling versions of its promising but unapproved weight-loss drug, retatrutide.
The Times
The Times20 hrs ago
Coroner links teenage student’s death to weight-loss drug Mounjaro
Coroner links teenage student’s death to weight-loss drug Mounjaro  The Times
CNBC
CNBC1 days ago
Eli Lilly takes weight-loss pill battle global with first Foundayo approval in Europe
Lilly's Foundayo wins U.K. approval, taking its weight-loss pill battle with Novo Nordisk's Wegovy beyond the U.S. market.
STAT News
STAT News1 days ago
Opinion: Burdensome Medicare GLP-1 program may keep patients from accessing $50 per month weight loss drugs
Medicare’s new weight loss drug program “risks creating barriers at precisely the moment when confidence in broader GLP‑1 coverage is most needed,” writes Jeffrey Millstein.
'Good news' as new weight loss drug approved for use in UK
The UK is the first country in Europe to approve Foundayo, a new weight loss pill that also treats type 2 diabetes. Find out who is eligible.
CTV News
CTV News1 days ago
New Alzheimer’s drug recommendation offers hope patients and families
A new recommendation from Canada’s Drug Agency could make an Alzheimer’s treatment more accessible to Canadians in the early stages of the disease.
The Herald
The Herald2 days ago
Weight-loss drugs reshape food and drink spending habits across Scotland
New research suggests GLP-1 weight-loss drugs are changing what Scottish consumers buy, with spending shifting away from snacks and processed foods towards healthier options.
New York Post
New York Post🏁 first to report2 days ago
Sudden death of California law student studying abroad linked to popular weight loss shot, inquest heard
Josephine Nasr, 19, died of a cardiac arrhythmia in her room at the University of East London in September 2025, an East London Coroner's Court heard last week.
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →